XALKORI gran 20 mg gélules à ouvrir bte 60 pce

7680694670012 CH-69467 L01ED01 07.16.1.

Active substances:

XALKORI gran 20 mg gélules à ouvrir bte 60 pce
XALKORI gran 20 mg gélules à ouvrir bte 60 pce
XALKORI gran 20 mg gélules à ouvrir bte 60 pce
1 / 3
google

Details

GTIN
7680694670012
Pharmacode
-
Product number
6946701
CPT
-
Packaging group
60
Unit
Kapsel(n)
Composition
crizotinibum 20 mg, alcohol stearylicus, poloxamerum 407, saccharum 5.71 mg, talcum, hypromellosum, macrogolum 4000, glyceroli mono/dipalmitas/stearas/oleas, triglycerida media, ad granulatum pro dosi.

Articles (1)

Xalkori 20 mg, filmüberzogenes Granulat zum Einnehmen
Granulat
60
View

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
crizotinibum
20.0 MG Substance Wirkstoff (Principe actif)
alcohol stearylicus
- Substance HNIDK
poloxamerum 407
- Substance HNIDK
saccharum
5.71 MG Substance HBESI
talcum
- Substance HNIDK
hypromellosum
- Substance HNIDK
macrogolum 4000
- Substance HNIDK
glyceroli mono/dipalmitas/stearas/oleas
- Substance HNIDK
triglycerida media
- Substance HNIDK

Authorization holder

Pfizer AG

8052 Zürich

Authorization information

Swissmedic authorization number
69467
Drug name
Xalkori, filmüberzogenes Granulat zum Einnehmen
Galenic form
GRFI
ATC Code
L01ED01
Authorization status
Z
Dispensation category
A
First authorization
29/08/2024
Authorization expiration date
28/08/2029
IT number
07.16.1.
Domain
Human medicine
Field of application
Onkologikum

Packaging details

Description (FR)
XALKORI gran 20 mg gélules à ouvrir bte 60 pce
Description (DE)
XALKORI Gran 20 mg Kapseln zum Öffnen Ds 60 Stk
Market launch
29/08/2024
Narcotic (BTM)
No

Other packaging sizes

XALKORI gran 50 mg gélules à ouvrir bte 60 pce
60 KAP
View
XALKORI gran 150 mg gélules à ouvrir bte 60 pce
60 KAP
View
Buy us a coffee Explore the data